1. Home
  2. CPT vs RDY Comparison

CPT vs RDY Comparison

Compare CPT & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden Property Trust

CPT

Camden Property Trust

HOLD

Current Price

$110.75

Market Cap

10.9B

Sector

Real Estate

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.22

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPT
RDY
Founded
1993
1984
Country
United States
India
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
11.6B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
CPT
RDY
Price
$110.75
$14.22
Analyst Decision
Buy
Strong Buy
Analyst Count
18
1
Target Price
$117.38
$16.90
AVG Volume (30 Days)
1.3M
2.1M
Earning Date
02-05-2026
01-20-2026
Dividend Yield
3.84%
0.51%
EPS Growth
135.73
5.58
EPS
3.54
0.76
Revenue
$1,586,767,000.00
$3,848,694,754.00
Revenue This Year
$1.97
$6.12
Revenue Next Year
$3.58
$2.58
P/E Ratio
$31.19
$18.54
Revenue Growth
2.02
11.09
52 Week Low
$97.17
$12.26
52 Week High
$126.55
$16.17

Technical Indicators

Market Signals
Indicator
CPT
RDY
Relative Strength Index (RSI) 59.54 61.39
Support Level $104.85 $14.00
Resistance Level $110.21 $14.23
Average True Range (ATR) 2.51 0.24
MACD 0.21 0.09
Stochastic Oscillator 83.79 96.86

Price Performance

Historical Comparison
CPT
RDY

About CPT Camden Property Trust

Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 177 multifamily properties comprised of nearly 59,996 apartment homes across the United States.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: